Key result
Electroconvulsive therapy safely treats major depression without adverse effects in 3 elderly patients with ICDs.
Why the study?
Is electroconvulsive therapy safe and effective in elderly patients with major depression and preexisting implantable cardioverter-defibrillators?
Case Report (n=3)
Is electroconvulsive therapy safe and effective in elderly patients with major depression and preexisting implantable cardioverter-defibrillators?
Answers are grounded in this paper and cite their sources.
Electroconvulsive therapy can be safely and effectively administered to elderly patients with major depression and preexisting implantable cardioverter-defibrillators when appropriate preventative measures are taken.
Electroconvulsive therapy has potent cardiovascular effects, which may pose a challenge in treating patients with preexisting cardiac disease. Although it is well studied in the treatment of refractory depression, there are still pitfalls to overcome when treating those with comorbid cardiovascular disease. The synergistic effects of depression and cardiovascular disease in affecting the morbidity and mortality of patients make treatment a significant issue. The authors discuss 3 elderly patients treated for major depression, all of whom previously had implantable cardioverter-defibrillators placed. All 3 patients were effectively treated, with no major adverse effects. The cases illustrate how taking the appropriate preventative measures allow even the most medically challenging patient to undergo effective treatment and highlight the debate surrounding the intraoperative management of implantable cardioverter-defibrillator devices.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2009) conducted a case report in Major depression with preexisting implantable cardioverter-defibrillators (n=3). Electroconvulsive therapy was evaluated on Treatment efficacy and major adverse effects. Electroconvulsive therapy was effectively and safely administered to 3 elderly patients with major depression and implantable cardioverter-defibrillators, with no major adverse effects.
Synapse has enriched 10 related papers. Consider them for comparative context: